Related Experiment Video
Updated: Jun 14, 2026

10:44
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Published on: February 2, 2011
48.7K
Donor Variability and Seeding Density Shape NK-Cell Proliferation and Surface Receptor Expression: Insights from an
Neele Kusch1,2, Jonathan Storm1,2, Antonia Macioszek1,3
1Department of Cell Biology, Bielefeld University, 33615 Bielefeld, Germany.
Cells
|August 27, 2025
Summary
Optimizing natural killer (NK) cell expansion for immunotherapy requires balancing seeding density and donor genetics. Standardized protocols are crucial for consistent, functional NK cell production.
Area of Science:
- Immunology
- Cell Biology
- Translational Medicine
Background:
- Natural killer (NK) cells are vital for adoptive immunotherapy.
- Clinical use necessitates standardized expansion protocols for sufficient, functional NK cells.
Purpose of the Study:
- To investigate how seeding density and donor variability impact NK cell expansion and receptor phenotype in vitro.
- To assess the role of genetic variations in NK cell receptor genes on expansion outcomes.
Main Methods:
- NK cells from healthy donors were expanded in G-Rex plates with IL-2.
- Longitudinal analysis using flow cytometry assessed cell proliferation and receptor expression.
- Targeted SNP sequencing of key receptor genes (IL2RA, IL2RB, FCGR3A, NCR1, KLRK1, ICAM-1) was performed.
Main Results:
- A seeding density of 2.0 × 10^6 cells/cm^2 favored high expansion and expression of activating receptors (CD16a, NKp46, NKG2D).
- Significant inter-donor variability in proliferation and receptor expression was observed.
- Some donors showed impaired expansion linked to specific SNPs, while others had robust growth without clear genetic drivers, suggesting non-genetic factors.
Conclusions:
- Both culture conditions (seeding density) and donor-intrinsic factors significantly influence NK cell expansion.
- Integrating phenotypic and genetic analyses is key to improving reproducibility and personalization of NK cell manufacturing for therapy.

